Although the prevalence of substance use disorders (SUDs) is higher among men, women with SUDs in low- and middle-income countries (LMICs) face unique challenges. Poverty and adversity, inequality of women, and disparities in access to treatment and prevention services exacerbate biological, psychological and social correlates of substance use disorders for women living in low-resource settings. Increasing the inclusion of women in research has long been a goal, though even high income countries struggle to achieve parity. In LMICs, women with SUDs are often neglected from global research due to underreporting and the disproportionate focus of global substance use research on men. We will discuss risk factors for SUDs that are particularly relevant for women residing in LMICs in order to gain insight into neglected areas of research and opportunities for prevention and treatment.
BlasE, KollerT, MagarV, ThomasR, VogelJ. (2014). Incorporating equity, gender, human rights and social determinants into guidelines. In: NorrisS. L., ed. WHO Handbook for Guideline Development. Geneva, Switzerland: World Health Organization.
2.
ClaytonJA.Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol Behav.2018;187:2–5.
3.
HeidariS, BaborTF, De CastroP, TortS, CurnoM.Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev.2016;1(1):2.
4.
LalR, DebKS, KediaS.Substance use in women: Current status and future directions. Indian J Psychiatry.2015;57(6):S275–S285.
5.
Medina-MoraME.Women and alcohol in developing countries. Salud Mental.2001;24(2):3–10.
AllenSS, AllenAM, KotlyarM, LunosS, Al'absiM, HatsukamiD.Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine Tob Res.2013;15(6):1091–1098.
8.
AllenSS, AllenAM, LunosS, HatsukamiDK.Patterns of self-selected smoking cessation attempts and relapse by menstrual phase. Addict Behav.2009;34(11):928–931.
9.
AnkerJJ, CarrollME.Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci2011;8:73–96.
10.
HudsonA, StampJA.Ovarian hormones and propensity to drug relapse: a review. Neurosci Biobehav Rev.2011;35(3):427–436.
11.
BaikJH.Dopamine signaling in reward-related behaviors. Front Neural Circuits2013;7:152.
12.
BobzeanSA, DeNobregaAK, PerrottiLI.Sex differences in the neurobiology of drug addiction. Exp Neurol.2014;259:64–74.
13.
ChartoffEH, MavrikakiM.Sex differences in kappa opioid receptor function and their potential impact on addiction. Front Neurosci2015;9:466.
14.
FattoreL.Considering gender in cannabinoid research: a step towards personalized treatment of marijuana addicts. Drug Test Anal.2013;5(1):57–61.
15.
GrazianiM, NenciniP, NisticoR.Genders and the concurrent use of cocaine and alcohol: pharmacological aspects. Pharmacol Res.2014;87:60–70.
16.
SofuogluM, MooneyM.Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Exp Clin Psychopharmacol.2009;17(2):63–69.
17.
BeckerJB, HuM.Sex differences in drug abuse. Front Neuroendocrinol.2008;29(1):36–47.
ManganyiMR.Home-brewed alcohol as a public health problem in Greater Tzaneen Municipality, Mopani District of Limpopo Province: a social work perspective. (Ph.D.). Mankwent, Limpopo, South Africa: University of Limpopo; 2015.
20.
Abarca-GómezL, AbdeenZA, HamidZA, . Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet2017;390(10113):2627–2642. doi:https://doi.org/10.1016/S0140-6736(17)32129-3
21.
HambidgeKM, KrebsNF, GarcésA, . Anthropometric indices for non-pregnant women of childbearing age differ widely among four low-middle income populations. BMC Public Health.2017;18(1):45.
22.
ConwayKP, SwendsenJ, HuskyMM, HeJP, MerikangasKR.Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the national comorbidity survey-adolescent supplement. J Am Acad Child Adolesc Psychiatry.2016;55(4):280–288.
23.
HoryniakD, MeloJS, FarrellRM, OjedaVD, StrathdeeSA.Epidemiology of substance use among forced migrants: a global systematic review. PLoS One.2016;11(7):e0159134.
24.
SabanA, FlisherAJ, GrimsrudA, . The association between substance use and common mental disorders in young adults: results from the South African Stress and Health (SASH) Survey. Pan Afr Med J.2014;17(Suppl 1):11.
25.
SwendsenJ, ConwayKP, DegenhardtL, . Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction.2010;105(6):1117–1128.
26.
WhitefordHA, DegenhardtL, RehmJ, . Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet2013;382(9904):1575–1586.
27.
PatelV.Mental health in low- and middle-income countries. Br Med Bull.2007;81–82(1):81–96.
28.
ObotIS, RoomR.Alcohol, Gender and Drinking Problems: Perspectives from Low and Middle Income Countries.Geneva, Switzerland: World Health Organization; 2005.
29.
StucklerD, McKeeM, EbrahimS, BasuS.Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med.2012;9(6):e1001235.
30.
CowlingK, ThowAM, Pollack PorterK.Analyzing the impacts of global trade and investment on non-communicable diseases and risk factors: a critical review of methodological approaches used in quantitative analyses. Global Health.2018;14(1):53.
31.
GilmoreAB, FooksG, DropeJ, BialousSA, JacksonRR.Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet2015;385(9972):1029–1043.
32.
ChowCK, CorsiDJ, GilmoreAB, . Tobacco control environment: cross-sectional survey of policy implementation, social unacceptability, knowledge of tobacco health harms and relationship to quit ratio in 17 low-income, middle-income and high-income countries. BMJ Open.2017;7(3):e013817.
33.
MbuloL, OgbonnaN, OlarewajuI, . Preventing tobacco epidemic in LMICs with low tobacco use – using Nigeria GATS to review WHO MPOWER tobacco indicators and prevention strategies. Prev Med.2016;91s:S9–S15.
34.
GilmoreAB, GallagherAWA, RowellA.Tobacco industry's elaborate attempts to control a global track and trace system and fundamentally undermine the Illicit Trade Protocol. Tob Control.2018;28:127–114.
35.
HiscockR, BranstonJR, McNeillA, HitchmanSC, PartosTR, GilmoreAB.Tobacco industry strategies undermine government tax policy: evidence from commercial data. Tob Control.2017;27:488–497.
36.
El MhamdiS, LemieuxA, Ben SalahA, . Exposure to community and collective violence during childhood and tobacco use patterns among young adults in Tunisia. Health Soc Care Community.2018;26(6):935–945.
37.
El MhamdiS, LemieuxA, BouaneneI, . Gender differences in adverse childhood experiences, collective violence, and the risk for addictive behaviors among university students in Tunisia. Prev Med.2017;99:99–104.
MendelsonJH, WeissR, GriffinM, . Some special considerations for treatment of drug abuse and dependence in women. In: PickensRW, LeukefeldCG, SchusterCR, eds. Improving Drug Abuse Treatment (Vol. Research Monograph 106). Rockville, MD: National Institute on Drug Abuse; 1991:313–326.
40.
al'AbsiM, NakajimaM, AllenS, LemieuxA, HatsukamiD.Sex differences in hormonal responses to stress and smoking relapse: a prospective examination. Nicotine Tob Res.2015;17(4):382–389.
41.
KonovaAB, MoellerSJ, ParvazMA, FroböseMI, Alia-KleinN, GoldsteinRZ.Converging effects of cocaine addiction and sex on neural responses to monetary rewards. Psychiatry Res.2016;248:110–118.
42.
WalitzerKS, DearingRL.Gender differences in alcohol and substance use relapse. Clin Psychol Rev.2006;26(2):128–148. Vol. United States.
43.
HodginsDC, El‐GuebalyN, AddingtonJ.Treatment of substance abusers: single or mixed gender programs?Addiction.1997;92(7):805–812.
44.
Nelson-ZlupkoL, KauffmanE, Morrison DoreM.Gender differences in drug addiction and treatment: implications for social work intervention with substance-abusing women. Social Work.1995;40(1):45–54.
45.
GreenfieldSF, BrooksAJ, GordonSM, . Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend.2007;86(1):1–21.
46.
DegenhardtL, StockingsE, StrangJ, MarsdenJ, HallWD.Illicit drug dependence. In: PatelV, ChisholmD, DuaT, LaxminarayanR, Medina-MoraME, eds. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities. 3rd ed, Vol. 4. Washington, DC: World Bank; 2016.
47.
Medina-MoraME, MonteiroM, RoomR, . Alcohol use and alcohol use disorders. In: PatelV, ChisholmD, DuaT, LaxminarayanR, Medina-MoraME, eds. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities. 3rd ed, Vol. 4. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2016.
48.
AshleyOS, MarsdenME, BradyTM.Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse.2003;29(1):19–53.
49.
CopelandJ, HallW.A comparison of women seeking drug and alcohol treatment in a specialist women's and two traditional mixed-sex treatment services. Br J Addict.1992;87(9):1293–1302.
50.
MarshJC, D'AunnoTA, SmithBD.Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction.2000;95(8):1237–1247.
51.
TuchmanE.Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis.2010;29(2):127–138.
52.
Ait-DaoudN, BlevinsD, KhannaS, SharmaS, HolstegeCP.Women and Addiction. Psychiatr Clin North Am.2017;40(2):285–297.
MyersB, CarneyT, WechsbergWM. “Not on the agenda”: a qualitative study of influences on health services use among poor young women who use drugs in Cape Town, South Africa. Int J Drug Policy2016;30:32–58.
55.
VernagliaTVC, LeiteTH, FallerS, Brazilian Crack Group, . The female crack users: higher rates of social vulnerability in Brazil. Health Care Women Int. 2017;38(11):1170–1187.
56.
ElwoodWN, CorriganJG, MorrisKA.NIH-funded CBPR: self-reported community partner and investigator perspectives. J Community Health.2019;44(4):740.
57.
SreeramareddyCT, HarperS, ErnstsenL.Educational and wealth inequalities in tobacco use among men and women in 54 low-income and middle-income countries. Tob Control.2018;27(1):26–34.
58.
Center for Substance Abuse Treatment. (2009). Substance Abuse Treatment: Addressing the Specific Needs of Women. Rockville, MD: Center for Substance Abuse Treatment.
59.
AdlerRH.Engel's biopsychosocial model is still relevant today. J Psychosom Res.2009;67(6):607–611.
60.
CarlinerH, DelkerE, FinkDS, KeyesKM, HasinDS.Racial discrimination, socioeconomic position, and illicit drug use among US Blacks. Soc Psychiatry Psychiatr Epidemiol.2016;51(4):551–560.
61.
ChengHL, MallinckrodtB.Racial/ethnic discrimination, posttraumatic stress symptoms, and alcohol problems in a longitudinal study of Hispanic/Latino college students. J Couns Psychol.2015;62(1):38–49.
62.
ChiandettiA, HernandezG, Mercadal-HallyM, . Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers. Reprod Health.2017;14(1):137.
63.
ClarkTT, Salas-WrightCP, VaughnMG, WhitfieldKE.Everyday discrimination and mood and substance use disorders: a latent profile analysis with African Americans and Caribbean Blacks. Addict Behav.2015;40:119–125.
64.
DelkerE, BrownQ, HasinDS.Alcohol consumption in demographic subpopulations: an epidemiologic overview. Alcohol Res2016;38(1):7–15.
65.
ErolA, KarpyakVM.Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. Drug Alcohol Depend.2015;156:1–13.
66.
ErtlV, SaileR, NeunerF, CataniC.Drinking to ease the burden: a cross-sectional study on trauma, alcohol abuse and psychopathology in a post-conflict context. BMC Psychiatry.2016;16(1):202.
67.
Garcia-MorenoC, JansenHAFM, EllsbergM, HeiseL, WattsCH.Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence. Lancet2006;368(9543):1260–1269.
68.
GoingsTC, HidalgoSJ, McGovernT.Similarities and differences in alcohol trajectories: testing the catch-up effect among biracial black subgroups. Addict Behav.2016;60:13–17.
69.
GoneJP. “It felt like violence”: Indigenous knowledge traditions and the postcolonial ethics of academic inquiry and community engagement. Am J Community Psychol.2017;60(3-4):353–360.
70.
HepburnM.Substance abuse in pregnancy. Curr Obstet Gynecol.2004;14(6):419–425.
71.
HolbrookBD, RayburnWF.Teratogenic risks from exposure to illicit drugs. Obstet Gynecol Clin North Am.2014;41(2):229–239.
72.
JacklinK, KinoshamegP.Developing a participatory aboriginal health research project: “only if it's going to mean something”. J Empirical Res Human Res Ethics.2008;3(2):53–67.
73.
KaneJC, Skavenski Van WykS, MurraySM, . Testing the effectiveness of a transdiagnostic treatment approach in reducing violence and alcohol abuse among families in Zambia: study protocol of the Violence and Alcohol Treatment (VATU) trial. Glob Ment Health (Camb).2017;4:e18.
74.
KoenenKC, RatanatharathornA, NgL, . Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med.2017;47(13):2260–2274.
75.
McHughRK, VotawVR, SugarmanDE, GreenfieldSF.Sex and gender differences in substance use disorders. Clin Psychol Rev.2018;66:12–23.
76.
MejiaR, KaplanCP, AldereteE, GregorichSE, Perez-StableEJ.Influence of gender role attitudes on smoking and drinking among girls from Jujuy, Argentina. Prev Med.2013;57(3):194–197.
77.
MerglerM, DriessenM, LüdeckeC, TRAUMAB-Studygroup, . Relationships between a dissociative subtype of PTSD and clinical characteristics in patients with substance use disorder. J Psychoactive Drugs.2017;49(3):225–232.
78.
MeyersJL, SartorCE, WernerKB, KoenenKC, GrantBF, HasinD.Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity?Psychol Med.2018;48(9):1540–1550.
79.
NIH Office of Research on Women's Health. Sex/gender. In: N. I. O. Health, ed. Bethesda, MD: National Institutes of Health; 2017.
80.
PachecoCM, DaleySM, BrownT, FilippiM, GreinerKA, DaleyCM.Moving forward: breaking the cycle of mistrust between American Indians and researchers. Am J Public Health.2013;103(12):2152–2159.
81.
RangmarJ, LiljaM, KöhlerM, ReuterA.Children who face development risks due to maternal addiction during pregnancy require extra medical and psychosocial resources. Acta Paediatr.2018;108:101–105.
82.
SeedatS, ScottKM, AngermeyerMC, . Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry.2009;66(7):785–795.
83.
SignorelliMC, HillelS, de OliveiraDC, Ayala QuintanillaBP, HegartyK, TaftA.Voices from low-income and middle-income countries: a systematic review protocol of primary healthcare interventions within public health systems addressing intimate partner violence against women. BMJ Open.2018;8(3):e019266.
84.
SithisarnT, GrangerDT, BadaHS.Consequences of prenatal substance use. Int J Adolesc Med Health.2012;24(2):105–112.
85.
United Nations Office on Drugs and Crime (2016a). World Drug Report 2016. Retrieved from: https://www.unodc.org/wdr2016/
86.
United Nations Office on Drugs and Crime (2018). World Drug Report 2018. Women and drugs: drug use, drug supply and their consequences. United Nations, Vienna, Austria, No. E.18.XI.9.
87.
VassolerFM, ByrnesEM, PierceRC.The impact of exposure to addictive drugs on future generations: physiological and behavioral effects. Neuropharmacology2014;76(Pt B):269–275.
88.
VondracekV, ProkupekJ, FischerR, AhrenbergovaM.Recent patterns of addiction in Czechoslovakia. Br J Psychiatry.1968;114(508):285–292.
89.
WendellAD.Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol.2013;56(1):91–96.
